BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,648,000 | +5.1% | 143,200 | +1.3% | 0.02% | +7.1% |
| Q2 2022 | $20,589,000 | +24.6% | 141,300 | +1.4% | 0.01% | +55.6% |
| Q1 2022 | $16,529,000 | -7.5% | 139,400 | +7.6% | 0.01% | -18.2% |
| Q4 2021 | $17,860,000 | -0.6% | 129,600 | +0.2% | 0.01% | 0.0% |
| Q3 2021 | $17,975,000 | +55.7% | 129,400 | +8.8% | 0.01% | +57.1% |
| Q2 2021 | $11,543,000 | +45.0% | 118,900 | +2.1% | 0.01% | +40.0% |
| Q1 2021 | $7,963,000 | -19.0% | 116,500 | +1.6% | 0.01% | -28.6% |
| Q4 2020 | $9,831,000 | +34.1% | 114,700 | +1.7% | 0.01% | +16.7% |
| Q3 2020 | $7,333,000 | -9.3% | 112,800 | +2.0% | 0.01% | -14.3% |
| Q2 2020 | $8,086,000 | +176.3% | 110,600 | +28.6% | 0.01% | +133.3% |
| Q1 2020 | $2,927,000 | -36.6% | 86,000 | +1.4% | 0.00% | -40.0% |
| Q4 2019 | $4,617,000 | +34.6% | 84,800 | +3.2% | 0.01% | +25.0% |
| Q3 2019 | $3,429,000 | -3.9% | 82,200 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $3,569,000 | +88.4% | 81,500 | +121.5% | 0.00% | +100.0% |
| Q1 2019 | $1,894,000 | +44.2% | 36,800 | +3.7% | 0.00% | 0.0% |
| Q4 2018 | $1,313,000 | +3.1% | 35,500 | +4.7% | 0.00% | +100.0% |
| Q3 2018 | $1,273,000 | +2.9% | 33,900 | +8.3% | 0.00% | 0.0% |
| Q2 2018 | $1,237,000 | +53.5% | 31,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $806,000 | +95.2% | 31,300 | +104.6% | 0.00% | – |
| Q4 2017 | $413,000 | – | 15,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |